Fox Chase Cancer Center News

New Matches to Urologic Oncology Fellowship Program

Two urologists from California and New York are the newest members of Fox Chase Cancer Center’s Urologic Oncology Fellowship program—they have initiated their 2-year training this summer. The fellowship program annually matches 2 urology residents, providing a unique, higher level and comprehensive experience in the treatment of genitourinary cancers.

VIEW STORY

Small Molecule Pak 1 Inhibitors May be an Effective Therapy for Colorectal Cancer

PHILADELPHIA (August 27, 2018) – A new study suggests that targeting Group I p21-activated kinases (Paks) with small-molecule inhibitors could be a promising therapeutic approach in colorectal cancer. Researchers led by Jonathan Chernoff, MD, PhD  designed a transgenic mouse model that conditionally expresses an inhibitory peptide to block the catalytic function of Group I Paks, and noted its efficacy in reducing adenomas and impeding progression to carcinomas. 

VIEW STORY

Fox Chase Cancer Center Proudly Supports the 20th Annual Run/Walk to Break the Silence on Ovarian Cancer

PHILADELPHIA (August 23, 2018) – Fox Chase Cancer Center is pleased to support the National Ovarian Cancer Coalition’s (NOCC) 20th Annual Philadelphia Run/Walk to Break the Silence on Ovarian Cancer. Faculty and staff, volunteers, patients, survivors, and their families will come together at this family-friendly 5K run/walk to raise funds to support ovarian cancer research and advocacy on Saturday, September 8.

VIEW STORY

Fox Chase Cancer Center Proudly Supports Miles for Melanoma Philadelphia

PHILADELPHIA (August 23, 2018) – As part of its ongoing commitment to community health, Fox Chase Cancer Center is pleased to support Miles for Melanoma 2018 in Philadelphia. Faculty and staff, volunteers, patients, survivors, and their families will come together at this family-friendly 5K run/walk to raise funds to support melanoma research, education, and advocacy through the Melanoma Research Foundation.

VIEW STORY